Response Pattern and Modeling of Tumor Treating Fields
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023884%3A_____%2F12%3A00007228" target="_blank" >RIV/00023884:_____/12:00007228 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Response Pattern and Modeling of Tumor Treating Fields
Original language description
Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor, with a global incidence of approximately 3.5 per 100,000 people. Despite standard treatment consisting of surgical resection together with radiotherapy and concomitant/ adjuvant temozolomide chemotherapy, the median overall survival(OS)for patients with newly diagnosed GBM is only 12 to 18 months. Nearly all patients with GBM experience disease progression despite aggressive first-line therapy, with a median time to progression of 6 to 11 months. Treatment options for GBM at the time of recurrence are limited, and there is no widely accepted standard treatment. Thus, new and more effective treatment options are highly desirable.
Czech name
—
Czech description
—
Classification
Type
C - Chapter in a specialist book
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Book/collection name
Alternating Electric Fields Therapy in Oncology
ISBN
978-3-319-30574-5
Number of pages of the result
11
Pages from-to
55-65
Number of pages of the book
129
Publisher name
Springer International Publishing
Place of publication
Basel
UT code for WoS chapter
—